PSY72 - THE ROLE OF CLINICAL OUTCOME ASSESSMENT DATA IN THE DRUG APPROVAL PROCESS OF PRODUCTS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY IN THE USA AND EUROPE: A REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS.

Subjects

Subjects :

*TREATMENT of Duchenne muscular dystrophy
*DRUG approval
*RARE diseases
*X-linked genetic disorders

Details

Language :

English

ISSN :

10983015

Volume :

19

Issue :

3

Database :

Academic Search Index

Journal :

Value in Health

Publication Type :

Academic Journal

Accession number :

115550740

Full Text :

https://doi.org/10.1016/j.jval.2016.03.1012